Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd.

¥8.81As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301126Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (17.41%)
Div yield 1.18%
ROE (12.74%)
Pharmaceutical Retailers
Beta (5Y) 0.68
PE TTM —
TSR TTM (27.17%)
Mkt cap ¥1.810B
ROIC 1.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
22.18%
13.34%
Hold 9|12|11|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.19
0.19
0.18
0.20
28.11%
16.49%
2.14%
3.93%
Revenue¥M
184.4
187.5
198.6
195.5
17.13%
12.58%
12.94%
4.98%
Peers (US$271.3M)
Cap (US$)
PE
304.2M
—
262.0M
18.33x
Capital
TTM
5Y
10Y
Leveragex
0.571
—
—
EBIT/Intx
0.100
1.083
0.886
Own earn%
71.24
(10.27)
(8.93)
Sh yield%
36.62
28.71
27.77
Owners
Insiders/Inst%
8.27
68.41
Short interest%
1.60
SBC / revenue%
0.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
20–28
$1 testx
—
Incr. ROIC%
18